Clinical Trials Sponsored by Jeffrey Kramer, MD

Total 27 results

Jeffrey Kramer, MD

Completed

Secondary Prevention After Coronary Bypass Surgery

Coronary Artery Disease

United States
Robert Kramer, MD
MaineHealth

Completed

The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery

Acute Kidney Injury | Acute Renal Insufficiency | Acute Kidney Insufficiency | Ischemic Preconditioning

United States
Jeffrey L Stimac MD

Recruiting

Fish Oil in Total Hip Replacement Randomized Clinical Trial

Total Hip Arthroplasty

United States
Jeffrey L Zitsman, MD

Completed

LAGB as a Treatment for Morbid Obesity in Adolescents

Obstructive Sleep Apnea Syndrome | Metabolic Syndrome | Insulin Resistance | Morbid Obesity | Nonalcoholic Fatty Liver Disease

United States
Jeffrey Alan Klein, MD

Not yet recruiting

Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline

Anesthesia, Local | Injection Site Irritation | Injection Site Discomfort | Injection Site Bruising | Benzoic Acid Adverse Reaction

United States
Jeffrey Alan Klein, MD

Not yet recruiting

Subcutaneous Injection of Large Volumes of Tumescent Lidocaine and Epinephrine by Laypersons (TLE-RCT)

Musculoskeletal Pain | Local Anesthesia | Regional Anesthesia | Dermatologic Surgery | Venomous Snakebites | Painless Injection | Cutaneous Pain

United States
Jeffrey A. Gusenoff, MD
University of Pittsburgh

Withdrawn

Offloading Device for Post Surgical Foot Procedures

Plantar Fascitis | Fat Pad Syndrome

United States
Jeffrey A. Gusenoff, MD

Completed

Validation of a Novel Foot Offloading Device (PopSole2)

Heel Pain Syndrome | Plantar Fasciitis, Chronic | Fat Pad Syndrome

United States
Jeffrey L Gum MD

Enrolling by invitation

Dronabinol for Post-operative Pain After Lumbar Fusion

Post-operative Pain

United States
Jeffrey Zwicker, MD
Quercegen Pharmaceuticals

Withdrawn

Isoquercetin in Sickle Cell Anemia

Sickle Cell Disease | Sickle Cell-Beta0-Thalassemia
Jeffrey B. Schwimmer, MD

Active, not recruiting

C15:0 Supplementation in Young Adults at Risk for Metabolic Syndrome

Metabolic Syndrome

United States
Jeffrey A. Lieberman, MD

Terminated

PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations

Schizophrenia
Jeffrey Veale, MD
OneLegacy Foundation

Recruiting

Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor (OneLegacy)

Tolerance | Renal Transplant Rejection | Kidney Transplant

United States
Jeffrey A. Cohen, MD
Jacobus Pharmaceutical

Terminated

Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) (3-4DAP)

Muscle Weakness

United States
Jeffrey J Crowley MD
AbbVie

Completed

MAP Study: Methotrexate and Adalimumab in Psoriasis (MAP)

Psoriasis

United States
Jeffrey Eugene, MD
Accreditation Council for Graduate Medical Education

Not yet recruiting

The Getting Real About The Talk (GReAT) Project - A Qualitative, Patient-Centered Evaluation of the Factors for Successfully Having 'The Talk' and Implementation for Attending and Trainee Physicians (GReAT)

Self Efficacy
Stephen G. Kaler, MD

Recruiting

NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome

Menkes Disease | Occipital Horn Syndrome

United States
Tanta University
Amer Galal Younis,MD

Completed

Evaluation of Neurotoxic Effect of Sevoflurane-Based AnaesthesiaGuided by Short-Term Olfactory Identification

Neurotoxic Effect of Sevoflurane-Based Anaesthesia

Egypt
Jeffrey Jenks, MD, MPH
Astellas Pharma Global Development, Inc.

Terminated

Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis (Isavu-CAPA)

Severe Acute Respiratory Syndrome Coronavirus 2 | Aspergillosis Invasive

United States
Jeffrey Zwicker, MD
National Heart, Lung, and Blood Institute (NHLBI); Quercegen Pharmaceuticals

Completed

Cancer Associated Thrombosis and Isoquercetin (CATIQ) (CATIQ)

Thromboembolism of Vein VTE in Colorectal Cancer | Thromboembolism of Vein in Pancreatic Cancer | Thromboembolism of Vein in Non-small Cell Lung Cancer

United States
Geoffrey Shapiro, MD, PhD
Eli Lilly and Company; AstraZeneca

Completed

Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

Solid Tumor

United States
Washington University School of Medicine
Dickson, Patricia I., M.D.; Milbrandt, Jeffrey, MD, PhD; Mitra, Rob, PhD; Turner...

Recruiting

Chromosome 9 P Minus Syndrome

Chromosome 9P Deletion Syndrome | 9p Minus Syndrome | Alfi Syndrome | 9P Monosomy | 9P Partial Monosomy Syndrome

United States
Jan M. Schwab, MD, PhD
Else Kröner Fresenius Foundation

Completed

Safety Study of Ibuprofen to Treat Acute Traumatic Spinal Cord Injury

Spinal Cord Injury

Germany
Jeffrey W. Clark, MD
Wyeth is now a wholly owned subsidiary of Pfizer; Dana-Farber Cancer Institute and other collaborators

Completed

Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer

Colorectal Cancer | Colorectal Adenocarcinoma

United States
Götz Thomalla, MD
Else Kröner-Fresenius-Stiftung (Foundation); Stroke Imaging Repositoy (STIR); MR Stroke Group

Completed

Identification of Stroke Patients ≤ 3 and ≤ 4.5 Hours of Symptom Onset by Fluid Attenuated Inversion Recovery (FLAIR) Imaging and Diffusion Weighted Imaging (DWI) (PRE-FLAIR)

Acute Ischemic Stroke

Germany
Toralf Reimer, MD PhD
European Breast Cancer Reseach Association of Surgical Trialists; University... and other collaborators

Recruiting

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

Breast Cancer | Breast Cancer Female

Spain, Austria, Germany, Italy
Christoph Gasche
Prof. Dr. Gabriela Möslein, Germany; Prof. Dr. Hans Vasen, The Netherlands; Prof... and other collaborators

Terminated

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (MesaCAPP)

Colorectal Cancer

Netherlands, Austria, Germany, Israel, Poland, Sweden

Clinical Trials Sponsored by Jeffrey Kramer, MD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations